Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors

Journal of Biomedical Optics

Volumn 15, Issue 3, 2010, Pages

  Miao, Zheng ^a   Ren, Gang ^a   Liu, Hongguang ^a   Jiang, Lei ^a   Cheng, Zhen ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Fluorescence; Infrared imaging; Optical materials; Optics; Targets; Tissue

Indexed keywords

AFFIBODY MOLECULES; ANTI-EGFR; BINDING AFFINITIES; BINDING SPECIFICITIES; BUNDLE STRUCTURES; CANCER BIOMARKERS; EPIDERMAL GROWTH FACTOR RECEPTORS; EX VIVO IMAGING; FLUORESCENT MICROSCOPY; HIGH SPECIFICITY; IN-VIVO; IN-VIVO IMAGING; MCF-7 CELLS; MOLECULAR IMAGING; MOLECULAR PROBES; NEAR INFRARED; NEAR-IR FLUORESCENCE; OPTICAL IMAGING; POSTINJECTION; SMALL SIZE; TUMOR TARGETING;

BINDING ENERGY; DISEASES; FLOW CYTOMETRY; FLUORESCENCE; GROWTH (MATERIALS); INFRARED DEVICES; INFRARED IMAGING; MOLECULES; OPTICAL IMAGE STORAGE; PEPTIDES; PROBES; SCAFFOLDS (BIOLOGY);

TUMORS;

CARBOCYANINE; CY5.5 CYANINE DYE; DIAGNOSTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; HYBRID PROTEIN; TUMOR MARKER;

ANIMAL; ANTIBODY AFFINITY; ARTICLE; CHEMISTRY; FEMALE; HUMAN; METABOLISM; METHODOLOGY; MOUSE; NEAR INFRARED SPECTROSCOPY; NEOPLASM; NUDE MOUSE; OPTICS; SPECTROFLUOROMETRY; SYNTHESIS; WHOLE BODY IMAGING; XENOGRAFT;

ANIMALS; ANTIBODY AFFINITY; CARBOCYANINES; FEMALE; HUMANS; MICE; MICE, NUDE; NEOPLASMS; OPTICS AND PHOTONICS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; SPECTROMETRY, FLUORESCENCE; SPECTROSCOPY, NEAR-INFRARED; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL; WHOLE BODY IMAGING;

EID: 78651462095     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3432738     Document Type: Article

References (32)

1. F. X. Real, W. J. Rettig, P. G. Chesa, M. R. Melamed, L. J. Old, and J. Mendelsohn, "Expression of epidermal growth factor receptor in human cultured cells and tissues," Cancer Res. 46(9), 4726-4731 (1986).
2. E. Van Cutsem, C. H. Köhne, E. Hitre, J. Zaluski, C. R. Chang Chien, A. Makhson, G. D'Haens, T. Pintér, R. Lim, G. Bodoky, J. K. Roh, G. Folprecht, P. Ruff, C. Stroh, S. Tejpar, M. Schlichting, J. Nippgen, and P. Rougier, "Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer," N. Engl. J. Med. 360(14), 1408-1417 (2009).
3. J. G. Paez, P. A. Jänne, J. C. Lee, S. Tracy, H. Greulich, S. Gabriel, P. Herman, F. J. Kaye, N. Lindeman, T. J. Boggon, K. Naoki, H. Sasaki, Y. Fujii, M. J. Eck, W. R. Sellers, B. E. Johnson, and M. Meyerson, "EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy," Science 304(5676), 1497-1500 (2004). (Pubitemid 38720929)
4. M. H. Cohen, J. R. Johnson, Y. F. Chen, R. Sridhara, and R. Pazdur, "FDA drug approval summary: erlotinib (Tarceva) tablets," Oncologist 10, 461-466 (2005). (Pubitemid 41266326)
5. 18F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors," Eur. J. Nucl. Med. Mol. Imaging 35(6), 1089-1099 (2008).
6. A. Pal, A. Glekas, M. Doubrovin, J. Balatoni, T. Beresten, D. Maxwell, S. Soghomonyan, A. Shavrin, L. Ageyeva, R. Finn, S. M. Larson, W. Bornmann, and J. G. Gelovani, "Molecular imaging of EGFR kinase activity in tumors with 124I-labeled small molecular tracer and positron emission tomography," Mol. Imaging Biol. 8(5), 262-277 (2006). (Pubitemid 44446020)
7. H. Wang, J. Yu, G. Yang, X. Song, X. Sun, S. Zhao, and D. Mu, "Assessment of 11C-labeled-4-N-(3-bromoanilino)-6,7-dimethoxyquinazoline as a positron emission tomography agent to monitor epidermal growth factor receptor expression," Cancer Sci. 98(9), 1413-1416 (2007). (Pubitemid 47241765)
8. J. P. Gleysteen, J. R. Newman, D. Chhieng, A. Frost, K. R. Zinn, and E. L. Rosenthal, "Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model," Head Neck 30(6), 782-789 (2008). (Pubitemid 351913856)
9. K. Wang, K. Wang, W. Li, T. Huang, R. Li, D. Wang, B. Shen, and X. Chen, "Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging," Acta Radiol. 11, 1-9 (2009).
10. C. R. Divgi, S. Welt, M. Kris, F. X. Real, S. D. J. Yeh, R. Gralla, B. Merchant, S. Schweighart, M. Unger, S. M. Larson, and J. Mendelsohn, "Phase I and imaging trial of indium-111-labeled antiepidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma," J. Natl. Cancer. Inst. (Bethesda) 83(2), 97-104 (1991).
11. R. J. Hosse, A. Rothe, and B. E. Power, "A new generation of protein display scaffolds for molecular recognition," Protein Sci. 15, 14-27 (2006). (Pubitemid 43004229)
12. H. K. Binz, P. Amstutz, and A. Pluckthun, "Engineering novel binding proteins from nonimmunoglobulin domains," Nat. Biotechnol. 23(10), 1257-1268 (2005). (Pubitemid 41486853)
13. K. Nord, E. Gunneriusson, J. Ringdahl, S. Ståhl, M. Uhlén, and P.Å. Nygren, "Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain," Nat. Biotechnol. 15(8), 772-777 (1997). (Pubitemid 27329481)
14. A. Orlova, V. Tolmachev, R. Pehrson, M. Lindborg, T. Tran, M. Sandström, F. Y. Nilsson, A. Wennborg, L. Abrahmsén, and J. Feld- wisch, "Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors," Cancer Res. 67(5), 2178-2186 (2007). (Pubitemid 46424237)
15. V. Tolmachev, A. Orlova, R. Pehrson, J. Galli, B. Baastrup, K. Andersson, M. Sandström, D. Rosik, J. Carlsson, H. Lundqvist, A. Wennborg, and F. Y. Nilsson, "Radionuclide therapy of HER2- positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule," Cancer Res. 67(6), 2773-2782 (2007). (Pubitemid 46548966)
16. Z. Cheng, O. P. De Jesus, M. Namavari, A. De, J. Levi, J. M. Webster, R. Zhang, B. Lee, F. A. Syud, and S. S. Gambhir, "Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules," J. Nucl. Med. 49(5), 804-813 (2008). (Pubitemid 351717547)
17. S. B. Lee, M. Hassan, R. Fisher, O. Chertov, V. Chernomordik, G. Kramer-Marek, A. Gandjbakhche, and J. Capala, "Affibody molecules for in vivo characterization of HER2-positive tumors by nearinfrared imaging," Clin. Cancer Res. 14(12), 3840-3849 (2008).
18. R. P. Baum, A. Orlova, V. Tolmachev, and J. Feldwisch, "Receptor PET/CT and SPECT using an Affibody molecule for targeting and molecular imaging of HER2-positive cancer in animal xenografts and human breast cancer patients, " J. Nucl. Med. 47(Supp. 1), 108P (2006).
19. T. Engfeldt, B. Renberg, H. Brumer, P.Å. Nygren, and A. E. Karlström, "Chemical synthesis of triple-labelled three-helix bundle binding proteins for specific fluorescent detection of unlabelled protein," ChemBioChem 6(6), 1043-1050 (2005). (Pubitemid 40825345)
20. M. Friedman, A. Orlova, E. Johansson, T. L. Eriksson, I. Höidén- Guthenberg, V. Tolmachev, F. Y. Nilsson, and S. Ståhl, "Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding Affibody molecule," J. Mol. Biol. 376(5), 1388-1402 (2008).
21. Z. Miao, G. Ren, H. Liu, L. Jiang, and Z. Cheng, "Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein," Bioconjugate Chem. 21(5), 947-954 (2010).
22. Z. Miao, G. Ren, H. Liu, L. Jiang, S. S. Gambhir, and Z. Cheng, "A protein scaffold based molecule for EGFR PET imaging," J. Nucl. Med. 50(supplement 2), 386 (2009).
23. V. Tolmachev, M. Friedman, M. Sandström, T. L. Eriksson, D. Rosik, M. Hodik, S. Ståhl, F. Y. Frejd, and A. Orlova, "Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry," J. Nucl. Med. 50(2), 274-283 (2009).
24. T. Troy, D. Jekic-McMullen, L. Sambucetti, and B. Rice, "Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models," Mol. Imaging 3(1), 9-23 (2004).
25. 3 expression in living mice," Bioconjugate Chem. 16(6), 1433-1441 (2005). (Pubitemid 41681509)
26. A. Nakayama, F. del Monte, R. J. Hajjar, and J. V. Frangioni, "Functional near-infrared fluorescence imaging for cardiac surgery and targeted gene therapy," Mol. Imaging 1(4), 365-77 (2002).
27. Z. Cheng, O. P. De Jesus, D. J. Kramer, A. De, J. M. Webster, O. Gheysens, J. Levi, M. Namavari, S. Wang, J. M. Park, R. Zhang, H. Liu, B. Lee, F. A. Syud, and S. S. Gambhir, "64Cu-labeled Affibody molecules for imaging of HER2 expressing tumors," Mol. Imaging Biol. 12, 316-324 (2009).
28. K. P. Withrow, J. R. Newman, J. B. Skipper, J. P. Gleysteen, J. S. Magnuson, K. Zinn, and E. L. Rosenthal, "Assessment of bevacizumab conjugated to Cy5.5 for detection of head and neck cancer xenografts," Technol. Cancer Res. Treat. 7(1), 61-66 (2008). (Pubitemid 351238697)
29. S. Ke, X. Wen, M. Gurfinkel, C. Charnsangavej, S. Wallace, E. M. Sevick-Muraca, and C. Li, "Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts," Cancer Res. 63(22), 7870-7875 (2003). (Pubitemid 37466721)
30. K. E. Adams, S. Ke, S. Kwon, F. Liang, Z. Fan, Y. Lu, K. Hirschi, M. E. Mawad, M. A. Barry, and E. M. Sevick-Muraca, "Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer," J. Biomed. Opt. 12(2), 024017 (2007).
31. A. Cuartero-Plaza, E. Martínez-Miralles, R. Rosell, C. Vadell-Nadal, M. Farré, and F. X. Real, "Radiolocalization of squamous lung carcinoma with 131I-labeled epidermal growth factor," Clin. Cancer Res. 2(1), 13-20 (1996).
32. P. Diagaradjane, J. M. Orenstein-Cardona, N. E. Colón-Casasnovas, A. Deorukhkar, S. Shentu, N. Kuno, D. L. Schwartz, J. G. Gelovani, and S. Krishnan, "Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe," Clin. Cancer Res. 14(3), 731-741 (2008). (Pubitemid 351231154)